Sharma T.K.,Health Science University |
Parchwani H.,J Ln Medical College |
Kaushik G.G.,J Ln Medical College |
Shankar V.,Health Science University |
And 3 more authors.
Clinical Laboratory | Year: 2011
Background: High levels of glycated hemoglobin (HbA 1c) have been associated with Coronary Vascular Diseases (CVD) in diabetic patients. Recent studies have reported no association between elevated glycated hemoglobin (HbA 1c) and incident cardiovascular disease (CVD) among women without diabetes. There are many controversial studies on topics such as "Glycated hemoglobin levels (HbA 1c) have been associated with cardiovascular diseases (CVD) in the non-diabetic patients". Therefore, we planned this study. Methods: The present study was conducted on 50 age matched controls and 50 clinically diagnosed non-diabetic CVD patients of either gender. The study included 50 patients with myocardial infarction (MI) admitted to the ICCU ward of J.L.N. Medical College and Hospital, Ajmer (Rajasthan). The following information was recorded from admission sheets of non-diabetic CVD patients of either gender: history of diabetes, hypertension, and cigarette smoking; demographic indices; coronary heart disease and diabetes mellitus treatment; serum cholesterol; serum triglycerides (TG); high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C); fasting and non-fasting blood glucose levels and Glycated haemoglobin levels (HbA1 c)• Glycosylated hemoglobin (HbA1 c) was measured by latex agglutination inhibition assay. Results and Conclusions: The HbA 1c levels in healthy controls (n = 50) and non-diabetic CVD subjects (n = 50) observed were 4.32 ± 0.34 % and 5.80 ± 0.20 %, respectively. HbA 1c levels in these subjects were significantly higher than controls (p <0.001). The HbA 1c levels in non-diabetic CVD patients are higher in comparison to controls.